14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TNXP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Tonix Pharmaceuticals stock price on Monday which ended trading at $0.146
(Updated on Apr 15, 2024)

Sell candidate since Mar 21, 2024 Loss -57.65% PDF

The Tonix Pharmaceuticals stock price fell by -10.22% on the last day (Monday, 15th Apr 2024) from $0.163 to $0.146. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 18.92% from a day low at $0.142 to a day high of $0.169. The price has fallen in 6 of the last 10 days and is down by -23.17% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $720.83 thousand.

Given the current short-term trend, the stock is expected to fall -26.12% during the next 3 months and, with a 90% probability hold a price between $0.108 and $0.232 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

TNXP Signals & Forecast

There are few to no technical positive signals at the moment. The Tonix Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.171 and $0.293. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -62.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Tonix Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Tonix Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0269 between high and low, or 18.92%. For the last week, the stock has had daily average volatility of 10.48%.

Tonix Pharmaceuticals is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TNXP) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Tonix Pharmaceuticals Holding Corp. to open at $0.152, and during the day (based on 14 day Average True Range), to move between $0.119 and $0.173, which gives a possible trading interval of +/-$0.0273 (+/-18.68%) up or down from last closing price. If Tonix Pharmaceuticals Holding Corp. takes out the full calculated possible swing range there will be an estimated 37.36% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.170, some $0.0241 (16.52%) from the current price of $0.146, our system finds the risk reward not very attractive.

Is Tonix Pharmaceuticals Holding Corp. stock A Buy?

Tonix Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.125 Strong Sell Candidate Unchanged

Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$0.152 ( 4.46%) $0.146

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TNXP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.179 22.89 %
R2 0.169 15.85 %
R1 0.163 11.50 %
Current price: 0.146
Support S1 0.142 -2.59 %
S2 0.136 -6.94 %
S3 0.126 -13.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.175 19.81 %
R2 0.173 18.85 %
R1 0.170 16.52 %
Current price 0.146
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Tonix Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Tonix Pharmaceuticals is TNXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tonix Pharmaceuticals Stock?
Tonix Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Tonix Pharmaceuticals Stock?
Tonix Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tonix Pharmaceuticals Stock.

What's the current price of Tonix Pharmaceuticals Stock?
As of the end of day on the 2024-04-15, the price of an Tonix Pharmaceuticals (TNXP) share was $0.146.

What is the 52-week high and low for Tonix Pharmaceuticals Stock?
The 52-week high for Tonix Pharmaceuticals Stock is $2.24 and the 52-week low is $0.142.

What is the market capitalization of Tonix Pharmaceuticals Stock?
As of the 2024-04-15, the market capitalization of Tonix Pharmaceuticals is 12.327M.

When is the next earnings date for Tonix Pharmaceuticals?
The upcoming earnings date for Tonix Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, auto... TNXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT